DE60334781D1 - Di-aryl-substituierte tetrazol-modulatoren des metabotropen glutamat-rezeptors-5 - Google Patents
Di-aryl-substituierte tetrazol-modulatoren des metabotropen glutamat-rezeptors-5Info
- Publication number
- DE60334781D1 DE60334781D1 DE60334781T DE60334781T DE60334781D1 DE 60334781 D1 DE60334781 D1 DE 60334781D1 DE 60334781 T DE60334781 T DE 60334781T DE 60334781 T DE60334781 T DE 60334781T DE 60334781 D1 DE60334781 D1 DE 60334781D1
- Authority
- DE
- Germany
- Prior art keywords
- modulators
- heteroaryl
- aryl substituted
- glutamate receptor
- metabotropic glutamate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36345602P | 2002-03-12 | 2002-03-12 | |
PCT/US2003/007074 WO2003077918A1 (en) | 2002-03-12 | 2003-03-07 | Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60334781D1 true DE60334781D1 (de) | 2010-12-16 |
Family
ID=28041770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60334781T Expired - Lifetime DE60334781D1 (de) | 2002-03-12 | 2003-03-07 | Di-aryl-substituierte tetrazol-modulatoren des metabotropen glutamat-rezeptors-5 |
Country Status (8)
Country | Link |
---|---|
US (1) | US7592337B2 (de) |
EP (1) | EP1485093B1 (de) |
JP (1) | JP4493341B2 (de) |
AT (1) | ATE486600T1 (de) |
AU (1) | AU2003213783B2 (de) |
CA (1) | CA2478799C (de) |
DE (1) | DE60334781D1 (de) |
WO (1) | WO2003077918A1 (de) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2295441T3 (es) * | 2001-12-18 | 2008-04-16 | MERCK & CO., INC. | Moduladores de pirazol heteroaril sustituido de receptor 5 metabotropico de glutamato. |
JP2006522130A (ja) * | 2003-04-03 | 2006-09-28 | メルク エンド カムパニー インコーポレーテッド | ナトリウムチャンネル遮断薬としてのビアリール置換ピラゾール |
EP1613614A2 (de) * | 2003-04-03 | 2006-01-11 | Merck & Co., Inc. | Diarylsubstituierte pyrazolmodulatoren des metabotropen glutamatrezeptors-5 |
WO2004087653A2 (en) * | 2003-04-03 | 2004-10-14 | Merck & Co., Inc. | 4-ring imidazole derivatives as modulators of metabotropic glutamate receptor-5 |
PL2256106T3 (pl) | 2003-07-22 | 2015-08-31 | Astex Therapeutics Ltd | Związki 3,4-pochodne 1h-pirazolu i ich zastosowanie jako kinazy zależne od cyklin (cdk) i modulatory kinazy syntazy glikogenu-3 (gsk-3) |
CA2537141A1 (en) * | 2003-09-02 | 2005-03-10 | Merck And Co., Inc. | Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 |
AU2005215379A1 (en) * | 2004-02-12 | 2005-09-01 | Merck & Co., Inc. | Bipyridyl amides as modulators of metabotropic glutamate receptor-5 |
US20070197549A1 (en) * | 2004-02-18 | 2007-08-23 | Astrazeneca Ab | Tetrazole compounds and their use as metabotropic glutamate receptor antagonists |
AU2005214375A1 (en) * | 2004-02-18 | 2005-09-01 | Astrazeneca Ab | Triazole compounds and their use as metabotropic glutamate receptor antagonists |
EP1716143A1 (de) * | 2004-02-18 | 2006-11-02 | AstraZeneca AB | Polyheterocyclische verbindungen und deren verwendung als antagonisten des metabotropen glutamatrezeptors |
TW200538108A (en) | 2004-02-19 | 2005-12-01 | Astrazeneca Ab | Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists |
EP1809620B1 (de) * | 2004-11-04 | 2010-12-29 | Addex Pharma SA | Neuartige tetrazolderivate als positive allosterische modulatoren von metabotropen glutamatrezeptoren |
AR054425A1 (es) | 2005-01-21 | 2007-06-27 | Astex Therapeutics Ltd | Sales de adicion de piperidin 4-il- amida de acido 4-(2,6-dicloro-benzoilamino) 1h-pirazol-3-carboxilico. |
US8404718B2 (en) | 2005-01-21 | 2013-03-26 | Astex Therapeutics Limited | Combinations of pyrazole kinase inhibitors |
EP2258359A3 (de) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenese durch Modulation des Muscarinrezeptors mit Sabcomelin |
JP2009506069A (ja) | 2005-08-26 | 2009-02-12 | ブレインセルス,インコーポレイティド | ムスカリン性受容体調節による神経発生 |
AU2006304787A1 (en) | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by PDE inhibition |
CA2625210A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
BRPI0709633B8 (pt) | 2006-03-29 | 2021-05-25 | Hoffmann La Roche | derivados de piridina e pirimidina como antagonistas de mglur2, composição farmacêutica e uso dos mesmos |
EP2026813A2 (de) | 2006-05-09 | 2009-02-25 | Braincells, Inc. | 5-ht-rezeptor-vermittelte neurogenese |
EP2377531A2 (de) | 2006-05-09 | 2011-10-19 | Braincells, Inc. | Neurogenese mittels Angiotensin-Modulation |
US7998971B2 (en) | 2006-09-08 | 2011-08-16 | Braincells Inc. | Combinations containing a 4-acylaminopyridine derivative |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
AR068921A1 (es) | 2007-10-19 | 2009-12-16 | Astrazeneca Ab | Derivados heterociclicos de tetrazol y 1,2-4 triazoles, composiciones farmaceuticas que los contienen y usos de los mismos para tratar desordenes neurologicos, gastrointestinales y del dolor,entre otros. |
WO2009054790A1 (en) * | 2007-10-26 | 2009-04-30 | Astrazeneca Ab | Amide linked heteroaromatic derivatives as modulators of mglur5 |
US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
EP2630133A1 (de) | 2010-10-22 | 2013-08-28 | Bayer Intellectual Property GmbH | Neue heterocylische verbindungen als schädlingsbekämpfungsmittel |
WO2013129021A1 (ja) * | 2012-02-28 | 2013-09-06 | 藤本化学製品株式会社 | 5-置換-2-アリール-2h-テトラゾールの製造方法 |
EP2914587A1 (de) | 2012-10-31 | 2015-09-09 | Bayer CropScience AG | Neue heterocylische verbindungen als schädlingsbekämpfungsmittel |
EA032075B1 (ru) | 2014-04-24 | 2019-04-30 | Новартис Аг | Производные аминопиразина в качестве ингибиторов фосфатидилинозитол-3-киназы |
CA2945257A1 (en) | 2014-04-24 | 2015-10-29 | Novartis Ag | Pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors |
BR112016024484A2 (pt) | 2014-04-24 | 2017-08-15 | Novartis Ag | derivados de aminopiridina como inibidores de fosfatidilinositol 3-quinase |
US9969726B2 (en) | 2014-06-10 | 2018-05-15 | Sanford-Burnham Medical Research Institute | Metabotropic glutamate receptor negative allosteric modulators (NAMS) and uses thereof |
CA3220329A1 (en) * | 2021-06-08 | 2022-12-15 | Andrew K. Shiau | Anticancer compounds |
WO2024015425A1 (en) | 2022-07-14 | 2024-01-18 | Fmc Corporation | Herbicidal benzoxazines |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE144248T1 (de) | 1992-07-01 | 1996-11-15 | Hoechst Ag | 3,4,5-substituierte benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament |
DE4306152A1 (de) | 1993-02-27 | 1994-09-01 | Hoechst Ag | Positiv arbeitendes strahlungsempfindliches Gemisch und damit hergestelltes Aufzeichnungsmaterial |
DE4318756A1 (de) | 1993-06-05 | 1994-12-08 | Hoechst Ag | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
EP0765867A1 (de) | 1995-09-27 | 1997-04-02 | Hoechst Aktiengesellschaft | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Antiarrhytmika oder Diagnostikum sowie sie enthaltendes Medikament |
DE19622370A1 (de) | 1996-06-04 | 1997-12-11 | Hoechst Ag | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
ID22426A (id) | 1996-12-11 | 1999-10-14 | Basf Ag | Ketobenzamida yang baru dan penggunaannya |
DK1210344T3 (da) * | 1999-08-19 | 2006-03-06 | Nps Pharma Inc | Heteropolycykliske forbindelser og anvendelser deraf som metabotrope glutamatreceptorantagonister |
US6660753B2 (en) | 1999-08-19 | 2003-12-09 | Nps Pharmaceuticals, Inc. | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
WO2003029210A2 (en) * | 2001-10-04 | 2003-04-10 | Merck & Co. Inc. | Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
AU2002365892A1 (en) | 2001-11-30 | 2003-06-17 | Merck & Co., Inc. | Metabotropic glutamate receptor-5 modulators |
ES2295441T3 (es) | 2001-12-18 | 2008-04-16 | MERCK & CO., INC. | Moduladores de pirazol heteroaril sustituido de receptor 5 metabotropico de glutamato. |
CA2469821C (en) | 2001-12-18 | 2009-10-20 | Merck & Co., Inc. | Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5 |
JP4357965B2 (ja) | 2001-12-21 | 2009-11-04 | メルク エンド カムパニー インコーポレーテッド | メタボトロピックグルタミン酸受容体−5のヘテロアリール置換ピロールモジュレーター |
US7148226B2 (en) | 2003-02-21 | 2006-12-12 | Agouron Pharmaceuticals, Inc. | Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
WO2004087653A2 (en) | 2003-04-03 | 2004-10-14 | Merck & Co., Inc. | 4-ring imidazole derivatives as modulators of metabotropic glutamate receptor-5 |
EP1613614A2 (de) | 2003-04-03 | 2006-01-11 | Merck & Co., Inc. | Diarylsubstituierte pyrazolmodulatoren des metabotropen glutamatrezeptors-5 |
WO2004089308A2 (en) | 2003-04-04 | 2004-10-21 | Merck & Co., Inc. | Di-aryl substituted pyrrole modulators of metabotropic glutamate receptor-5 |
US7268151B2 (en) | 2003-04-04 | 2007-09-11 | Merck & Co., Inc. | Di-aryl substituted triazole modulators of metabotropic glutamate receptor-5 |
CA2537141A1 (en) | 2003-09-02 | 2005-03-10 | Merck And Co., Inc. | Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 |
AU2005215379A1 (en) | 2004-02-12 | 2005-09-01 | Merck & Co., Inc. | Bipyridyl amides as modulators of metabotropic glutamate receptor-5 |
-
2003
- 2003-03-07 AT AT03711474T patent/ATE486600T1/de not_active IP Right Cessation
- 2003-03-07 US US10/506,479 patent/US7592337B2/en active Active
- 2003-03-07 CA CA002478799A patent/CA2478799C/en not_active Expired - Fee Related
- 2003-03-07 DE DE60334781T patent/DE60334781D1/de not_active Expired - Lifetime
- 2003-03-07 AU AU2003213783A patent/AU2003213783B2/en not_active Ceased
- 2003-03-07 EP EP03711474A patent/EP1485093B1/de not_active Expired - Lifetime
- 2003-03-07 WO PCT/US2003/007074 patent/WO2003077918A1/en active Application Filing
- 2003-03-07 JP JP2003575971A patent/JP4493341B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2478799A1 (en) | 2003-09-25 |
WO2003077918A1 (en) | 2003-09-25 |
EP1485093B1 (de) | 2010-11-03 |
JP4493341B2 (ja) | 2010-06-30 |
AU2003213783A1 (en) | 2003-09-29 |
ATE486600T1 (de) | 2010-11-15 |
CA2478799C (en) | 2009-12-29 |
US7592337B2 (en) | 2009-09-22 |
JP2005526081A (ja) | 2005-09-02 |
AU2003213783B2 (en) | 2007-01-25 |
EP1485093A1 (de) | 2004-12-15 |
EP1485093A4 (de) | 2005-12-28 |
US20050153986A1 (en) | 2005-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60334781D1 (de) | Di-aryl-substituierte tetrazol-modulatoren des metabotropen glutamat-rezeptors-5 | |
ATE374194T1 (de) | Heteroarylsubstituierte triazolmodulatoren des metabotropen glutamatarezeptors 5 | |
WO2004089303A3 (en) | Di-aryl substituted pyrazole modulators of metabotropic glutamate receptor-5 | |
WO2004089306A3 (en) | Di-aryl substituted triazole modulators of metabotropic glutamate receptor-5 | |
WO2004089308A3 (en) | Di-aryl substituted pyrrole modulators of metabotropic glutamate receptor-5 | |
WO2005079802A8 (en) | Bipyridyl amides as modulators of metabotropic glutamate receptor-5 | |
WO2003053922A3 (en) | Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5 | |
WO2003051833A3 (en) | Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 | |
DE60226756D1 (de) | Heteroarylsubstituierte tetrazolmodulatoren des metabotropischen glutamatrezeptors-5 | |
WO2004087653A3 (en) | 4-ring imidazole derivatives as modulators of metabotropic glutamate receptor-5 | |
HUP0202636A2 (hu) | Alkilén-diamin-csoporttal helyettesített heterogyűrűs vegyületek és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
DK0975595T3 (da) | Kokainanaloger | |
DE60231341D1 (de) | Fluor- und sulfonylaminohaltige, 3,6-disubstituierptorantagonisten | |
BR0211740A (pt) | Compostos espiro | |
CN101316834A (zh) | 在2位取代有苯基的1h-苯并咪唑-4-甲酰胺是强效parp抑制剂 | |
TW200634016A (en) | Novel thieno-pyridine and thieno-pyrimidine derivatives and their use as positive allosteric modulators of mglur2-receptors | |
BR0205829A (pt) | Novas aminas como ligantes dos receptores de histamina-3 e suas aplicações terapêuticas | |
ATE451368T1 (de) | Azabicyclische verbindungen zur linderung von schmerzen und zur behandlung von erkrankungen des zentralen nervensystems | |
CY1111615T1 (el) | Αρυλβινυλαζακυκλοαλκανια και μεθοδοι παρασκευης και χρησεως τους. | |
ATE402704T1 (de) | Dopamin-d3-rezeptor-liganden zur behandlung von sucht | |
ATE398614T1 (de) | Triazolverbindungen und ihre therapeutische verwendung | |
MXPA05013233A (es) | Derivados de imidazol heteroaril-substituidos como antagonistas del receptor de glutamato. | |
TW200512197A (en) | Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptors | |
Moldes et al. | Synthesis and preliminary biological evaluation at the glycineB site of (+)-and (−)-3-oxetanylglycine, novel non-proteinogenic amino acids | |
ATE418973T1 (de) | Spirocyclopropyl-amide und -säuren und ihre therapeutischen anwendungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R081 | Change of applicant/patentee |
Ref document number: 1485093 Country of ref document: EP Owner name: SCHERING CORPORATION, US Free format text: FORMER OWNER: MERCK SHARP & DOHME CORP., RAHWAY, US Effective date: 20121213 |
|
R082 | Change of representative |
Ref document number: 1485093 Country of ref document: EP Representative=s name: ABITZ & PARTNER, DE Effective date: 20121213 |